Clinical Trials Browser

Solid Tumor Malignancy × 90 days × Clear all

NCT06911489 2026-02-02

Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor Malignancy